These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3315195)

  • 41. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study.
    Friedman HS; Krischer JP; Burger P; Oakes WJ; Hockenberger B; Weiner MD; Falletta JM; Norris D; Ragab AH; Mahoney DH
    J Clin Oncol; 1992 Feb; 10(2):249-56. PubMed ID: 1732426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group.
    Ettinger LJ; Gaynon PS; Krailo MD; Ru N; Baum ES; Siegel SE; Hammond GD
    Cancer; 1994 Feb; 73(4):1297-301. PubMed ID: 8313334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase I trial of procarbazine as a 5-day continuous infusion in children with central nervous system tumors.
    van Eys J; Cangir A; Pack R; Baram T
    Cancer Treat Rep; 1987 Oct; 71(10):973-4. PubMed ID: 3308081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of NCI-sponsored phase I trials with carboplatin.
    Foster BJ; Clagett-Carr K; Leyland-Jones B; Hoth D
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():43-9. PubMed ID: 3910221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase I study of carboplatin given on a five-day intravenous schedule.
    Rozencweig M; Nicaise C; Beer M; Crespeigne N; Van Rijmenant M; Lenaz L; Kenis Y
    J Clin Oncol; 1983 Oct; 1(10):621-6. PubMed ID: 6366128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Phase II study of carboplatin in malignant lymphoma].
    Naito K; Kobayashi M; Oyama A; Kodera Y; Tanaka M; Kamiya O; Mitomo Y; Ohno R; Sampi K; Hirano M
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2145-51. PubMed ID: 3293537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study).
    Arseneau J; Blessing JA; Stehman FB; McGehee R
    Invest New Drugs; 1986; 4(2):187-91. PubMed ID: 3525449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II trial of carboplatin in patients with advanced melanoma.
    Casper ES; Bajorin D
    Invest New Drugs; 1990 May; 8(2):187-90. PubMed ID: 1696568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II studies of combinations of drugs with high dose carboplatin in neuroblastoma (800 mg/m2 to 1 g 250/m2): a report from the LMCE group.
    Philip T; Gentet JC; Carrie C; Farge A; Meziane F; Bouffet E; Zucker JM; Kremens B; Brunat-Mentigny M
    Prog Clin Biol Res; 1988; 271():573-82. PubMed ID: 3043453
    [No Abstract]   [Full Text] [Related]  

  • 50. Phase II evaluation of carboplatin in advanced esophageal carcinoma. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society.
    Queisser W; Preusser P; Mross KB; Fritze D; Rieche K; Beyer JH; Achterrath W; Edler L
    Onkologie; 1990 Jun; 13(3):190-3. PubMed ID: 2204004
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.
    Gaynon PS; Ettinger LJ; Baum ES; Siegel SE; Krailo MD; Hammond GD
    Cancer; 1990 Dec; 66(12):2465-9. PubMed ID: 2249186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion.
    Koeller JM; Trump DL; Tutsch KD; Earhart RH; Davis TE; Tormey DC
    Cancer; 1986 Jan; 57(2):222-5. PubMed ID: 3510700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A phase I study of carboplatin in children with acute leukemia in bone marrow relapse. A report from the Childrens Cancer Group.
    Ettinger LJ; Krailo MD; Gaynon PS; Hammond GD
    Cancer; 1993 Aug; 72(3):917-22. PubMed ID: 8334645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase I studies with carboplatin at the Royal Marsden Hospital.
    Calvert AH; Harland SJ; Newell DR; Siddik ZH; Harrap KR
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():51-7. PubMed ID: 3910222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carboplatin in advanced, refractory germ cell neoplasms: a phase II Eastern Cooperative Oncology Group Study.
    Trump DL; Elson P; Brodovsky H; Vogl SE
    Cancer Treat Rep; 1987 Oct; 71(10):989-90. PubMed ID: 2820572
    [No Abstract]   [Full Text] [Related]  

  • 56. Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors.
    Allen J; Packer R; Bleyer A; Zeltzer P; Prados M; Nirenberg A
    J Clin Oncol; 1991 May; 9(5):783-8. PubMed ID: 2016620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer.
    Wagstaff AJ; Ward A; Benfield P; Heel RC
    Drugs; 1989 Feb; 37(2):162-90. PubMed ID: 2649354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A phase II trial of carboplatin (NSC 241240) in advanced prostate cancer, refractory to hormonal therapy. An Eastern Cooperative Oncology Group pilot study.
    Trump DL; Marsh JC; Kvols LK; Citrin D; Davis TE; Hahn RG; Vogl SE
    Invest New Drugs; 1990; 8 Suppl 1():S91-4. PubMed ID: 2199402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multicenter phase II study of spiroplatin.
    Tanis BC; Vermorken JB; ten Bokkel Huinink WW; van Oosterom AT; Splinter TA; Vendrik KJ; Sleijfer DT; van der Burg ME; van der Putten E; Pinedo HM
    Oncology; 1992; 49(2):99-103. PubMed ID: 1574259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of CHIP (iproplatin) in recurrent pediatric malignant solid tumors. A phase II study (Pediatric Oncology Group).
    Nitschke R; Pratt C; Harris M; Krischer J; Vietti TJ; Grier H; Kamps W; Toledano S
    Invest New Drugs; 1992 Jul; 10(2):93-6. PubMed ID: 1323551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.